Transaction in Own Shares

Summary by AI BETAClose X

Legal & General Group Plc has purchased 6,659,783 of its ordinary shares between April 13th and April 17th, 2026, as part of its share buyback program announced on March 11th, 2026. These repurchased shares will be cancelled, reducing the total number of ordinary shares in issue to 5,662,331,182, which also represents the total number of voting rights. The highest price paid per share was £273.30 and the lowest was £257.45, with a weighted average price across the period.

Disclaimer*

Legal & General Group Plc
20 April 2026
 

LEGAL & GENERAL GROUP PLC
ISIN: GB0005603997
20th April 2026

 

LEI number: 213800JH9QQWHLO99821

 

Legal & General Group Plc (the "Company")
Transaction in Own Shares


The Company announces that from 13th April 2026 up to and including 17th April 2026 it had purchased a total of 6,659,783 of its ordinary shares of 2.5 pence each (the "ordinary shares"), through the Company's broker Barclays Capital Securities Limited as detailed below. The repurchased ordinary shares will be cancelled.

Date

Aggregate number of ordinary shares purchased

Highest price paid (per ordinary share)

Lowest price paid (per ordinary share)

Volume weighted average price

 

Trading venue

13th April 2026

425,706

260.10

257.65

259.22

XLON

13th April 2026

217,115

260.10

257.45

259.05

BATE

13th April 2026

258,431

260.15

257.50

259.01

TRQX

13th April 2026

117,432

260.05

257.45

259.10

AQXE

13th April 2026

381,316

260.15

257.50

259.07

CHIX

14th April 2026

161,709

262.95

260.70

262.27

XLON

14th April 2026

136,589

262.95

260.65

262.29

BATE

14th April 2026

151,145

262.95

260.60

262.27

TRQX

14th April 2026

87,470

262.95

260.90

262.35

AQXE

14th April 2026

222,870

262.95

260.60

262.24

CHIX

15th April 2026

472,534

266.20

264.40

265.60

XLON

15th April 2026

235,780

266.30

264.65

265.51

BATE

15th April 2026

279,468

266.30

264.60

265.49

TRQX

15th April 2026

151,844

266.30

264.40

265.51

AQXE

15th April 2026

360,374

266.30

264.40

265.55

CHIX

16th April 2026

627,911

268.00

266.10

267.70

XLON

16th April 2026

203,135

268.00

265.90

267.55

BATE

16th April 2026

183,436

268.00

265.90

267.42

TRQX

16th April 2026

144,573

268.00

265.90

267.52

AQXE

16th April 2026

340,945

268.00

265.90

267.53

CHIX

17th April 2026

511,040

273.30

268.50

270.76

XLON

17th April 2026

195,896

273.10

268.50

270.67

BATE

17th April 2026

269,068

273.30

268.50

270.57

TRQX

17th April 2026

136,707

273.20

268.65

270.09

AQXE

17th April 2026

387,289

273.30

268.50

270.58

CHIX


The purchases form part of the Company's share buyback programme announced on 11th March 2026.

Following settlement of the above purchases and cancellation of the purchased ordinary shares, the Company's total number of ordinary shares in issue shall be 5,662,331,182 ordinary shares.

No ordinary shares are held in treasury. Therefore, the total number of voting rights in the Company is 5,662,331,182.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as incorporated into and implemented under English law (including by virtue of the European Union (Withdrawal) Act 2018), the detailed breakdown of individual trades made by Barclays Capital Securities Limited on behalf of the Company as part of the share buyback programme is set out below.

http://www.rns-pdf.londonstockexchange.com/rns/1914B_1-2026-4-20.pdf

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings